| comorbidity: An R Package for Computing Comorbidity Scores A Gasparini Journal of Open Source Software 3, 648, 2018 | 237 | 2018 |
| Incidence and determinants of hyperkalemia and hypokalemia in a large healthcare system E Nilsson, A Gasparini, J Ärnlöv, H Xu, KM Henriksson, J Coresh, ... International Journal of Cardiology 245, 277-284, 2017 | 177 | 2017 |
| Hyperkalemia after initiating renin–angiotensin system blockade: the Stockholm Creatinine Measurements (SCREAM) Project G Bandak, Y Sang, A Gasparini, AR Chang, SH Ballew, M Evans, J Arnlov, ... Journal of the American Heart Association 6 (7), e005428, 2017 | 171 | 2017 |
| Association between proton pump inhibitor use and risk of progression of chronic kidney disease DCF Klatte, A Gasparini, H Xu, P de Deco, M Trevisan, ALV Johansson, ... Gastroenterology 153 (3), 702-710, 2017 | 167 | 2017 |
| Prevalence and recognition of chronic kidney disease in Stockholm healthcare A Gasparini, M Evans, J Coresh, ME Grams, O Norin, AR Qureshi, ... Nephrology Dialysis Transplantation, gfw354, 2016 | 159 | 2016 |
| Measures of chronic kidney disease and risk of incident peripheral artery disease: a collaborative meta-analysis of individual participant data K Matsushita, SH Ballew, J Coresh, H Arima, J Ärnlöv, M Cirillo, N Ebert, ... The Lancet Diabetes & Endocrinology 5 (9), 718-728, 2017 | 130 | 2017 |
| Albuminuria changes are associated with subsequent risk of end-stage renal disease and mortality JJ Carrero, ME Grams, Y Sang, J Ärnlöv, A Gasparini, K Matsushita, ... Kidney international 91 (1), 244-251, 2017 | 128 | 2017 |
| The Stockholm CREAtinine Measurements (SCREAM) project: protocol overview and regional representativeness B Runesson, A Gasparini, AR Qureshi, O Norin, M Evans, P Barany, ... Clinical kidney journal 9 (1), 119-127, 2016 | 95 | 2016 |
| Time in therapeutic range and outcomes after warfarin initiation in newly diagnosed atrial fibrillation patients with renal dysfunction K Szummer, A Gasparini, S Eliasson, J Ärnlöv, AR Qureshi, P Bárány, ... Journal of the American Heart Association 6 (3), e004925, 2017 | 90 | 2017 |
| Relationship of estimated GFR and albuminuria to concurrent laboratory abnormalities: an individual participant data meta-analysis in a global consortium LA Inker, ME Grams, AS Levey, J Coresh, M Cirillo, JF Collins, ... American Journal of Kidney Diseases 73 (2), 206-217, 2019 | 80 | 2019 |
| eGFR and the risk of community-acquired infections H Xu, A Gasparini, J Ishigami, K Mzayen, G Su, P Barany, J Ärnlöv, ... Clinical Journal of the American Society of Nephrology 12 (9), 1399-1408, 2017 | 72 | 2017 |
| Plasma potassium ranges associated with mortality across stages of chronic kidney disease: the Stockholm CREAtinine Measurements (SCREAM) project A Gasparini, M Evans, P Barany, H Xu, T Jernberg, J Ärnlöv, LH Lund, ... Nephrology Dialysis Transplantation 34 (9), 1534-1541, 2019 | 55 | 2019 |
| Lower serum calcium is independently associated with CKD progression CJ Janmaat, M Van Diepen, A Gasparini, M Evans, AR Qureshi, J Ärnlöv, ... Scientific reports 8 (1), 5148, 2018 | 41 | 2018 |
| Use of nephrotoxic medications in adults with chronic kidney disease in Swedish and US routine care A Bosi, Y Xu, A Gasparini, B Wettermark, P Barany, R Bellocco, LA Inker, ... Clinical Kidney Journal 15 (3), 442-451, 2022 | 33 | 2022 |
| rsimsum: Summarise results from Monte Carlo simulation studies A Gasparini Journal of Open Source Software 3 (26), 739, 2018 | 32 | 2018 |
| Mixed‐effects models for health care longitudinal data with an informative visiting process: A Monte Carlo simulation study A Gasparini, KR Abrams, JK Barrett, RW Major, MJ Sweeting, NJ Brunskill, ... Statistica Neerlandica 74 (1), 5-23, 2020 | 31 | 2020 |
| Low renal replacement therapy incidence among slowly progressing elderly chronic kidney disease patients referred to nephrology care: an observational study UH Lundström, A Gasparini, R Bellocco, AR Qureshi, JJ Carrero, M Evans BMC nephrology 18, 1-10, 2017 | 26 | 2017 |
| Cinacalcet use and the risk of cardiovascular events, fractures and mortality in chronic kidney disease patients with secondary hyperparathyroidism M Evans, S Methven, A Gasparini, P Barany, K Birnie, S MacNeill, MT May, ... Scientific reports 8 (1), 1-9, 2018 | 25 | 2018 |
| Defining measures of kidney function in observational studies using routine health care data: methodological and reporting considerations JJ Carrero, EL Fu, SV Vestergaard, SK Jensen, A Gasparini, ... Kidney international 103 (1), 53-69, 2023 | 22 | 2023 |
| Impact of model misspecification in shared frailty survival models A Gasparini, MS Clements, KR Abrams, MJ Crowther Statistics in medicine 38 (23), 4477-4502, 2019 | 18 | 2019 |
